Barreiro-Pérez Manuel, González-Ferreiro Rocío, Caneiro-Queija Berenice, Tavares-Silva Marta, Puga Luis, Parada-Barcia Jose A, Rodriguez-Perez Alvaro, Baz-Alonso Jose A, Pinon-Esteban Miguel A, Estevez-Loureiro Rodrigo, Iniguez-Romo Andres
Cardiology Department, Galicia Sur Health Research Institute (IISGS), University Hospital Alvaro Cunqueiro, 36213 Vigo, Spain.
Cardiac Surgery Department, Galicia Sur Health Research Institute (IISGS), University Hospital Alvaro Cunqueiro, 36213 Vigo, Spain.
J Clin Med. 2023 Feb 9;12(4):1371. doi: 10.3390/jcm12041371.
Tricuspid regurgitation (TR) is one of the most common heart valve diseases, associated a with poor prognosis since significant TR is associated with an increased mortality risk compared to no TR or mild regurgitation. Surgery is the standard treatment for TR, although it is associated with high morbidity, mortality, and prolonged hospitalization, particularly in tricuspid reoperation after left-sided surgery. Thus, several innovative percutaneous transcatheter approaches for repair and replacement of the tricuspid valve have gathered significant momentum and have undergone extensive clinical development in recent years, with favorable clinical outcomes in terms of mortality and rehospitalization during the first year of follow-up. We present three clinical cases of transcatheter tricuspid valve replacement in an orthotopic position with two different innovative systems along with a review of the state-of-the-art of this emergent topic.
三尖瓣反流（TR）是最常见的心脏瓣膜疾病之一，由于严重TR与无TR或轻度反流相比，死亡风险增加，因此其预后较差。手术是TR的标准治疗方法，尽管它与高发病率、死亡率和延长住院时间相关，尤其是在左侧手术后进行三尖瓣再次手术时。因此，近年来，几种用于修复和置换三尖瓣的创新经皮导管方法获得了显著发展，并经历了广泛的临床开发，在随访的第一年，在死亡率和再住院方面取得了良好的临床结果。我们展示了三例使用两种不同创新系统原位经导管置换三尖瓣的临床病例，并对这一新兴主题的最新进展进行了综述。
